SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Megan Ehret, Applying Pharmacogenomics in Therapeutics, 2016,

    CrossRef

  2. 2
    Sarah G Helton, Falk W Lohoff, Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders, Pharmacogenomics, 2015, 16, 5, 541

    CrossRef

  3. 3
    Mervi Kautto, Olli Kampman, Nina Mononen, Terho Lehtimäki, Susann Haraldsson, Pasi A. Koivisto, Esa Leinonen, Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: Susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression, Neuroscience Letters, 2015, 590, 116

    CrossRef

  4. 4
    Barbara Breitenstein, Sandra Scheuer, Florian Holsboer, Are there meaningful biomarkers of treatment response for depression?, Drug Discovery Today, 2014, 19, 5, 539

    CrossRef

  5. 5
    Olivia F. O'Leary, Fionn E. O'Brien, Richard M. O'Connor, John F. Cryan, Drugs, genes and the blues: Pharmacogenetics of the antidepressant response from mouse to man, Pharmacology Biochemistry and Behavior, 2014, 123, 55

    CrossRef

  6. 6
    Chiara Fabbri, Alessandro Minarini, Tomihisa Niitsu, Alessandro Serretti, Understanding the pharmacogenetics of selective serotonin reuptake inhibitors, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 8, 1093

    CrossRef

  7. 7
    C. Anthony Altar, John Hornberger, Ashwini Shewade, Victor Cruz, Jill Garrison, David Mrazek, Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy, International Review of Psychiatry, 2013, 25, 5, 509

    CrossRef

  8. 8
    Chiara Fabbri, Giulia Di Girolamo, Alessandro Serretti, Pharmacogenetics of antidepressant drugs: An update after almost 20 years of research, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2013, 162, 6
  9. 9
    Giovanni Severino, Alessio Squassina, Marta Costa, Claudia Pisanu, Stefano Calza, Martin Alda, Maria Del Zompo, Mirko Manchia, Pharmacogenomics of bipolar disorder, Pharmacogenomics, 2013, 14, 6, 655

    CrossRef

  10. 10
    Stefano Porcelli, Chiara Fabbri, Alessandro Serretti, Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy, European Neuropsychopharmacology, 2012, 22, 4, 239

    CrossRef

  11. 11
    Sneha Narasimhan, Falk W Lohoff, Pharmacogenetics of antidepressant drugs: current clinical practice and future directions, Pharmacogenomics, 2012, 13, 4, 441

    CrossRef

  12. 12
    Judith R. Homberg, Serotonin and decision making processes, Neuroscience & Biobehavioral Reviews, 2012, 36, 1, 218

    CrossRef

  13. 13
    Paolo Olgiati, Emanuele Bajo, Marco Bigelli, Diana De Ronchi, Alessandro Serretti, Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 36, 1, 147

    CrossRef

  14. 14
    Alessandro Serretti, Sara Gibiino, Paolo Olgiati, Neurobiology of Psychiatric Disorders, 2012,

    CrossRef

  15. 15
    Alessandro Serretti, Paolo Olgiati, Emanuele Bajo, Marco Bigelli, Diana De Ronchi, A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders, World Journal of Biological Psychiatry, 2011, 12, 7, 501

    CrossRef

  16. 16
    Robert Keers, Katherine J Aitchison, Pharmacogenetics of antidepressant response, Expert Review of Neurotherapeutics, 2011, 11, 1, 101

    CrossRef

  17. 17
    Ulrich Rabl, Christian Scharinger, Markus Müller, Lukas Pezawas, Imaging genetics: implications for research on variable antidepressant drug response, Expert Review of Clinical Pharmacology, 2010, 3, 4, 471

    CrossRef

  18. 18
    M Kato, A Serretti, Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder, Molecular Psychiatry, 2010, 15, 5, 473

    CrossRef

  19. 19
    Peter P. Zandi, Jennifer T. Judy, The Promise and Reality of Pharmacogenetics in Psychiatry, Clinics in Laboratory Medicine, 2010, 30, 4, 931

    CrossRef

  20. 20
    Peter P. Zandi, Jennifer T. Judy, The Promise and Reality of Pharmacogenetics in Psychiatry, Psychiatric Clinics of North America, 2010, 33, 1, 181

    CrossRef

  21. 21
    Masaki Kato, Raffaella Zanardi, David Rossini, Diana De Ronchi, Gaku Okugawa, Toshihiko Kinoshita, Cristina Colombo, Alessandro Serretti, 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients, Psychiatry Research, 2009, 167, 1-2, 97

    CrossRef

  22. 22
    Svetlana Oestergaard, Claus Møldrup, Application of pharmacogenomics to clinical problems in depression, Personalized Medicine, 2009, 6, 5, 501

    CrossRef

  23. 23
    Cristina Lanni, Stefano Govoni, Adele Lucchelli, Cinzia Boselli, Depression and antidepressants: molecular and cellular aspects, Cellular and Molecular Life Sciences, 2009, 66, 18, 2985

    CrossRef

  24. 24
    Sonja Horstmann, Elisabeth B. Binder, Pharmacogenomics of antidepressant drugs, Pharmacology & Therapeutics, 2009, 124, 1, 57

    CrossRef

  25. 25
    Alessandro Serretti, Francesco Benedetti, Laura Mandelli, Raffaella Calati, Barbara Caneva, Cristina Lorenzi, Valentina Fontana, Cristina Colombo, Enrico Smeraldi, Association between GSK-3β -50T/C polymorphism and personality and psychotic symptoms in mood disorders, Psychiatry Research, 2008, 158, 2, 132

    CrossRef

  26. 26
    A Serretti, M Kato, J L Kennedy, Pharmacogenetic studies in depression: a proposal for methodologic guidelines, The Pharmacogenomics Journal, 2008, 8, 2, 90

    CrossRef

  27. 27
    Sefi Kronenberg, Amos Frisch, Beni Rotberg, Miri Carmel, Alan Apter, Abraham Weizman, Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety, Pharmacogenomics, 2008, 9, 11, 1725

    CrossRef

  28. 28
    Gary M. Levin, Toya M. Bowles, Megan J. Ehret, Taimour Langaee, Jennifer Y. Tan, Julie A. Johnson, William J. Millard, Assessment of Human Serotonin 1A Receptor Polymorphisms and SSRI Responsiveness, Molecular Diagnosis & Therapy, 2007, 11, 3, 155

    CrossRef

  29. 29
    S. Anttila, K. Huuhka, M. Huuhka, R. Rontu, K. M. Mattila, E. Leinonen, T. Lehtimäki, Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression, Journal of Neural Transmission, 2007, 114, 4, 461

    CrossRef

  30. 30
    TADAFUMI KATO, Molecular genetics of bipolar disorder and depression, Psychiatry and Clinical Neurosciences, 2007, 61, 1
  31. 31
    Mugdha Thakur, Iris Grossman, Douglas C McCrory, Lori A Orlando, David C Steffens, Kathryn E Cline, Rebecca N Gray, Jennifer Farmer, Georgette Dejesus, Cara O'Brien, Gregory Samsa, David B Goldstein, David B Matchar, Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors, Genetics in Medicine, 2007, 9, 12, 826

    CrossRef

  32. 32
    Iris Grossman, Routine pharmacogenetic testing in clinical practice: dream or reality?, Pharmacogenomics, 2007, 8, 10, 1449

    CrossRef

  33. 33
    Bárbara Arias, Alessandro Serretti, Cristina Lorenzi, Cristóbal Gastó, Rosa Catalán, Lourdes Fañanás, Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin, Journal of Affective Disorders, 2006, 90, 2-3, 251

    CrossRef

  34. 34
    David S. Jones, Roy H. Perlis, Pharmacogenetics, Race, and Psychiatry: Prospects and Challenges, Harvard Review of Psychiatry, 2006, 14, 2, 92

    CrossRef

  35. 35
    Elisabeth B. Binder, Florian Holsboer, Pharmacogenomics and antidepressant drugs, Annals of Medicine, 2006, 38, 2, 82

    CrossRef

  36. 36
    Alessandro Serretti, Cristina Cusin, Jeffrey L. Rausch, Brigitta Bondy, Enrico Smeraldi, Pooling pharmacogenetic studies on the serotonin transporter: A mega-analysis, Psychiatry Research, 2006, 145, 1, 61

    CrossRef

  37. 37
    Jorge A. Cervilla, Margarita Rivera, Esther Molina, Francisco Torres-González, Juan A. Bellón, Berta Moreno, Juan de Dios Luna, José A. Lorente, Yolanda de Diego-Otero, Michael King, Irwin Nazareth, Blanca Gutiérrez, The 5-HTTLPR s/s genotype at the serotonin transporter gene (SLC6A4) increases the risk for depression in a large cohort of primary care attendees: The PREDICT-gene study, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006, 141B, 8
  38. 38
    Charles A. Henry, Ronald Steingard, Jacob Venter, Jeff Guptill, Elkan F. Halpern, Margaret Bauman, Treatment Outcome and Outcome Associations in Children with Pervasive Developmental Disorders Treated with Selective Serotonin Reuptake Inhibitors: A Chart Review, Journal of Child and Adolescent Psychopharmacology, 2006, 16, 1-2, 187

    CrossRef

  39. 39
    Current awareness in human psychopharmacology, Human Psychopharmacology: Clinical and Experimental, 2005, 20, 3
  40. 40
    H J Cho, I Meira-Lima, Q Cordeiro, L Michelon, P Sham, H Vallada, D A Collier, Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis, Molecular Psychiatry, 2005, 10, 8, 771

    CrossRef

  41. 41
    Liangfu Chen, Joseph W. Polli, ADME Pharmacogenomics in Drug Development,
  42. 42
    Ichiro M Omori, Norio Watanabe, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Hugh McGuire, Rachel Churchill, Toshi A Furukawa, Fluvoxamine versus other anti-depressive agents for depression, The Cochrane Library,